Skip to content
Login Register

#insulin production

8 public questions tagged with this topic.

Gene Therapy

Cyanogen bromide is used in insulin production to:

Cyanogen bromide chemical cleavage exquisite selectivity methionine residues enabling precise excision fusion partner. Mechanism involves nucleophilic attack thioether sulfur methionine electrophilic carbon CNBr generating cyanosulfonium intermediate undergoing intramolecular cyclization carbonyl oxygen forming iminolactone ring subsequently hydrolyzed acidic conditions homoserine lactone C-terminal cleavage site while N-terminal fragment released. Specificity exploited recombinant insulin manufacturing where fusion proteins engineered single methionine codon junction between beta-galactosidas

Ref: Methods Enzymol Cyanogen Bromide Cleavage Meinke 1981; Watson Molecular Biology Protein Cleavage Methods; NCERT Biotechnology Bioprocess Cleavage Techniques.

View Details
Gene Therapy

Recombinant insulin production involves fusion with:

Early industrial production human insulin 1982 relied fusion protein technology because small 51 aa insulin A 21 B 30 rapidly degraded bacterial cytoplasm proteases Lon Clp if expressed mature alone. Genentech team Riggs Boyer Goeddel chemically synthesized DNA encoding insulin chains separately fused carboxy terminus E. coli beta-galactosidase 1024 aa enzyme encoded lacZ or trp leader peptide. Large fusion drove formation insoluble inclusion bodies protecting heterologous peptide from proteolysis enabling purification centrifugation detergent washes. Construct single methionine codon junction

Ref: Science History Institute Recombinant Insulin LacZ Fusion 1982; NCBI Bookshelf Insulin Fusion Production; Goeddel et al PNAS 1979 Insulin Expression.

View Details